David Henry Aggen
12PUBLICATIONS
162CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Feb 02, 2026
Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran
|Dec 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.Rana R McKay, Sumanta Pal, Wanling Xie
|Nov 03, 2025
IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial Carcinoma.David H Aggen, Meredith McKean, Jean H Hoffman-Censits
|Sep 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.Andrea Necchi, Matthew D Galsky, Nazli Dizman
|Sep 13, 2024
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer.Matthew C Dallos, Aleksandar Z Obradovic, Patrick McCann
|May 01, 2024
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran
Pageof 2
Frequent Collaborators
7 joint publications
Jonathan Rosenberg
5 joint publications
Hikmat Al-Ahmadie
4 joint publications
Samuel Funt
4 joint publications
Bernard H Bochner
4 joint publications
Min Yuen Teo
4 joint publications
Gopa Iyer
3 joint publications
Chung-Han Lee
3 joint publications
Eugene K Cha
3 joint publications
Eugene Pietzak
3 joint publications
Ashley Regazzi
